ALTEROLA BIOTECH INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Alterola Biotech Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2018 to Q2 2024.
  • Alterola Biotech Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$419K, a 6.21% increase year-over-year.
  • Alterola Biotech Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$2.35M, a 37.6% decline year-over-year.
  • Alterola Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$2.37M, a 14.6% decline from 2022.
  • Alterola Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.07M, a 504% decline from 2021.
  • Alterola Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$343K, a 10.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2.35M -$419K +$27.7K +6.21% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q1 2024 -$2.37M $206K +$555K Jan 1, 2024 Mar 31, 2024 10-K 2024-07-18
Q4 2023 -$2.93M -$2.01M -$1.48M -276% Oct 1, 2023 Dec 31, 2023 10-Q/A 2024-02-21
Q3 2023 -$1.45M -$123K +$252K +67.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-21
Q2 2023 -$1.71M -$447K +$366K +45% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q1 2023 -$2.07M -$348K +$5.99M +94.5% Jan 1, 2023 Mar 31, 2023 10-K 2024-07-18
Q4 2022 -$8.06M -$535K +$2.27M +80.9% Oct 1, 2022 Dec 31, 2022 10-Q/A 2024-02-21
Q3 2022 -$10.3M -$375K -$113K -43.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-21
Q2 2022 -$10.2M -$813K -$662K -440% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 -$9.55M -$6.33M -$5.99M -1747% Jan 1, 2022 Mar 31, 2022 10-Q 2023-02-14
Q4 2021 -$3.56M -$2.8M -$2.74M -4417% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 -$818K -$262K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$151K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-18
Q1 2021 -$343K Jan 7, 2021 Mar 31, 2021 10-K/A 2022-09-14
Q4 2020 -$62K -$36.3K -141% Oct 1, 2020 Dec 31, 2020 10-Q 2021-05-28
Q4 2019 -$25.7K +$26.9K +51.2% Oct 1, 2019 Dec 31, 2019 10-Q 2021-04-02
Q4 2018 -$52.6K Oct 1, 2018 Dec 31, 2018 10-Q 2020-12-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.